Bio-Rad Laboratories, Inc. Class A Common Stock vs Bumble Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Bumble Inc trades at $2.95 (market cap $406.29M). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 19.7× Bumble Inc's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Bumble Inc nearer its low. Which is the better fit depends on your goals.
| BIO | BMBL | |
|---|---|---|
Market Cap | $8.02B | $406.29M |
Sector | Health | Technology |
52-Week High | $339.75 | $8.57 |
52-Week Low | $241.71 | $2.70 |
Enterprise Value | $7.84B | $757.97M |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.
Read more on BMBL →